HIGHLIGHTS
- who: Parul Gupta et al. from the Department of Respiratory Medicine, King George`s Medical University, Lucknow, Uttar Pradesh, India have published the research: The Anti-Tumor and Immunomodulatory Effects of PLGA-Based Docetaxel Nanoparticles in Lung Cancer: The Potential Involvement of Necroptotic Cell Death through Reactive Oxygen Species and Calcium Build-Up, in the Journal: Vaccines 2022, 1801 of /2022/
- what: The authors synthesized polylactic-co-glycolic acid (PLGA) nanoparticles encapsulating and evaluated their efficacy in non-small cell lung carcinoma (A549) cells and primary immune cells derived from humans. nanoparticles (PLGA-Dtx) were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.